SIRIO PHARMA CO LT revenue for the last year amounted to 3.58 B CNY, the most of which — 1.53 B CNY — came from its highest performing source at the moment, Soft Capsules, the year earlier bringing 991.46 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought SIRIO PHARMA CO LT 1.85 B CNY, and the year before that — 1.49 B CNY.